A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae100 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Yosef Nissim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Ocean University Medical Center, Brick, NJ, USA. Hauptthemen laut MEDLINE: Meropenem, Ertapenem, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Ocean University Medical Center, Brick, NJ, USA.
- Department of Pathology and Laboratory Medicine, UConn Health, Farmington, CT, USA.
- Departments of Clinical Pharmacy and Medicine (Section of Infectious Diseases), SOP Global Affairs Liaison, West Virginia University, 1124 Health Sciences North, P.O. Box 9520, Morgantown, WV 26506-9520, USA.
ORCID-Profile: Douglas Slain
Zitieren
APA
Nissim, Y., LaSala, P. R., & Slain, D. (2024). A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae100
Vancouver
Nissim Y, LaSala PR, Slain D. A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae100
BibTeX
@article{Nissim2024,
author = {Nissim, Yosef and LaSala, P Rocco and Slain, Douglas},
title = {A serial passage experiment to assess the development of resistance to ertapenem and meropenem among Enterobacterales},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae100}
}
EUVIMED